Skip to main
RVTY

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 45%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

Revvity's stock outlook is positively influenced by its strategic transition from traditional testing (TST) to Interferon Gamma Release Assays (IGRA), anticipated to drive annual market growth by several basis points. The company boasts a diversified product portfolio, highlighted by a high-growth software segment—Signals—which accounts for approximately 10% of sales, alongside a robust immunodiagnostics franchise contributing around 30% of sales. Furthermore, Revvity has demonstrated enhanced profitability potential through operating leverage, expanding market share in key areas such as autoimmune testing and reagents, which positions the company favorably for sustained long-term financial success.

Bears say

Revvity's performance in the Chinese market has been severely impacted, particularly in the immunodiagnostics segment, which saw a significant decline in revenue, recording a downward percentage decrease in 2Q25, further contributing to a projected reduction in overall revenue contribution from China to approximately 7% by 2025. Additionally, the company faces potential headwinds from unfavorable economic conditions and cuts in industry funding, which may lead to decreased customer demand for its products and adversely affect growth and market share. Furthermore, macroeconomic challenges such as product shortages, inflation, transit delays, and labor shortages pose risks to Revvity's supply chain and operational efficacy, further complicating the company's financial outlook.

Revvity Inc (RVTY) has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 45% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Buy based on their latest research and market trends.

According to 11 analysts, Revvity Inc (RVTY) has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $112.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $112.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.